Cindy Jacobs M.D., Ph.D.
Net Worth

Last updated:

What is Cindy Jacobs M.D., Ph.D. net worth?

The estimated net worth of Dr. Cindy Jacobs M.D., Ph.D. is at least $8,389,674 as of 19 Apr 2024. He owns shares worth $209,023 as insider, has earned $63,311 from insider trading and has received compensation worth at least $8,117,340 in Achieve Life Sciences, Inc..

What is the salary of Cindy Jacobs M.D., Ph.D.?

Dr. Cindy Jacobs M.D., Ph.D. salary is $579,810 per year as Pres, Chief Medical Officer & Director in Achieve Life Sciences, Inc..

How old is Cindy Jacobs M.D., Ph.D.?

Dr. Cindy Jacobs M.D., Ph.D. is 67 years old, born in 1958.

What stocks does Cindy Jacobs M.D., Ph.D. currently own?

As insider, Dr. Cindy Jacobs M.D., Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Achieve Life Sciences, Inc. (ACHV) Pres, Chief Medical Officer & Director 77,416 $2.7 $209,023

What does Achieve Life Sciences, Inc. do?

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

ACHV logo
ACHV
Achieve Life Sciences, Inc.
$2.7

Cindy Jacobs M.D., Ph.D. insider trading

Achieve Life Sciences, Inc.

Dr. Cindy Jacobs M.D., Ph.D. has made 8 insider trades between 2011-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 20,000 units of ACHV stock on 12 Aug 2014. As of 19 Apr 2024 he still owns at least 77,416 units of ACHV stock.

Transaction Date Security Shares Price per share Total value Source
Option
Performance Restricted Stock Unit (PRSU) 16,250 N/A N/A
Option
Common Stock 16,250 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 2,500 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 16,250 N/A N/A
Option
Common Stock 16,250 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 2,500 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Restricted Stock Unit (RSU) 68 N/A N/A
Option
Common Stock 68 N/A N/A
Option
Restricted Stock Unit (RSU) 69 N/A N/A
Option
Common Stock 69 N/A N/A
Option
Restricted Stock Unit (RSU) 1,370 N/A N/A
Option
Restricted Stock Unit (RSU) 42 N/A N/A
Option
Common Stock 42 N/A N/A
Option
Common Stock 2,856 N/A N/A
Option
Restricted Stock Unit (RSU) 1,441 N/A N/A
Option
Common Stock 2,856 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Restricted Stock Unit (RSU) 5,000 N/A N/A
Option
Restricted Stock Unit (RSU) 10,312 N/A N/A
Option
Common Stock 10,312 N/A N/A
Option
Restricted Stock Unit (RSU) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 1,437 $1.03 $1,473
Sale
Common Stock 3,254 $0.83 $2,701
Option
Restricted Stock 1,875 $0.85 $1,594
Option
Restricted Stock Unit (RSU) 10,313 N/A N/A
Option
Common Stock 12,188 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Restricted Stock Unit (RSU) 5,000 N/A N/A
Sale
Common Stock 1,408 $2.69 $3,788
Sale
Common Stock 2,092 $1.88 $3,933
Option
Restricted Stock Unit (RSU) 7,500 $0.62 $4,650
Option
Common Stock 7,500 N/A N/A
Option
Common Stock 13,400 N/A N/A
Option
Restricted Stock Unit (RSU) 13,400 N/A N/A
Option
Restricted Stock Unit (RSU) 4,950 N/A N/A
Option
Common Stock 4,950 N/A N/A
Sale
Common Stock 5,650 $3.17 $17,911
Option
Common Stock 20,000 N/A N/A
Option
Restricted Stock Unit (RSU) 20,000 N/A N/A
Sale
Common Stock 1,250 $12.25 $15,313
Option
Restricted Stock Unit (RSU) 4,375 $5.9 $25,791
Option
Common Stock 4,375 N/A N/A
Sale
Common Stock 1,364 $8.68 $11,840
Option
Restricted Stock Unit (RSU) 4,593 N/A N/A
Option
Common Stock 4,593 N/A N/A
Option
Restricted Stock Unit (RSU) 1,875 $11.95 $22,406
Sale
Common Stock 534 $11.9 $6,355
Option
Common Stock 1,875 $11.95 $22,406
Option
Stock Options 11,210 N/A N/A
Option
Common Stock 11,210 N/A N/A
Option
Stock Options 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A

Achieve Life Sciences key executives

Achieve Life Sciences, Inc. executives and other stock owners filed with the SEC: